3 news items
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
CRSP
8 May 24
also secured reimbursed access for eligible people with SCD or TDT in KSA and Bahrain, as well as for people with TDT in France through an early
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
CRSP
13 Mar 24
authorities may not approve exa-cel on a timely basis or at all; adequate pricing or reimbursement may not be secured to support continued development
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
CRSP
21 Feb 24
. Additionally, Vertex is actively engaging with state Medicaid organizations to secure immediate reimbursement and coverage for CASGEVY
- Prev
- 1
- Next